Clinical & translational oncology

• 

  Año 2022, Vol. 24, Número 10 (October)

  • Review Article

    • Overcome tumor relapse in CAR T cell therapy

      Cheng-Dong Huo, Jie Yang, Yan-Mei Gu, Dai-Jun Wang, Xiao Zhang, Yu-Min Li

      • Resumen

      págs. 1833-1843

      

    • Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis

      Chandra Prakash Prasad, Ajay Gogia, Atul Batra

      • Resumen

      págs. 1844-1855

      

    • CDC7 as a novel biomarker and druggable target in cancer

      Runze Liu, Yong Huang

      • Resumen

      págs. 1856-1864

      

    • Glycosylation and its research progress in endometrial cancer

      Congli Pu, Biyuan Biyuan, Kai Xu, Yingchao Zhao

      • Resumen

      págs. 1865-1880

      

    • The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target

      Somayeh Vafaei, Hamed Taheri, Yasamin Hajimomeni, Amirhossein Fakhre Yaseri, Firoozeh Abolhasani Zadeh

      • Resumen

      págs. 1881-1889

      

  • Special Article

    • Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

      José Manuel Trigo Pérez, Mónica García-Cosío Piqueras, Almudena García Castaño, Montserrat Gomà Gallego, Ricard Mesía Nin, E. Ruiz Bravo-Burguillos, Ainara Soria, Paola Castillo Fernandez, Irene Braña Garcia, Margarita Alberola Ferranti

      • Resumen

      págs. 1890-1902

      

  • Research Article

    • Diagnostic impact of 18F-FDG PET/CT imaging on the detection of immune-related adverse events in patients treated with immunotherapy

      Gamze Tatar, Göksel Alçin, Nilay Sengul Samanci, Özge Erol Fenercioglu, Ediz Beyhan, Tevfik Fikret Çermik

      • Resumen

      págs. 1903-1913

      

    • Effect of PPP1R14D gene high expression in lung adenocarcinoma knocked out on proliferation and apoptosis of DMS53 cell

      Ye Tian, Liguo Guan, Yuting Qian, Yue Wu, Zexin Gu

      • Resumen

      págs. 1914-1923

      

    • Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology

      Javier Bosque Moreno, Carlos Miguel Guirao Rubio, Asia Ferrández, Noelia Suarez, María Isabel Castillejo Castillo, Diana Anguita, María Pamies, Alejandro Moya, José Luis Soto Martínez, Javier Gallego Plazas

      • Resumen

      págs. 1924-1931

      

    • Spinal cord compression of neoplastic origin: surgical experience using a common clinical language

      Oscar Godino, Ignacio Visus, Iago Garreta, Luis López Obarrio, Lluis González Cañas, Juan José Sánchez Fernández, María del Mar Marin Melia, Abelardo Montero Sáez, Héctor Pérez Montero, Leyre Asiaín, Arturo Navarro Martín

      • Resumen

      págs. 1932-1939

      

    • MiR-6511b-5p suppresses metastasis of pMMR colorectal cancer through methylation of CD44 by directly targeting BRG1

      JinMing Sun, Ling Ye, Yuan Shi, XingWei Wang, XiaFei Zhao, ShengYong Ren, JunWei Fan, HuanZhang Shao, BingYu Qin

      • Resumen

      págs. 1940-1953

      

    • FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p

      Dongbo Luo, Adili Salai, Hongbo Lv, Yang Wang, Yunfei Gao

      • Resumen

      págs. 1954-1963

      

    • FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer

      Lei Liu, Yecai Huang, Yan Li, Qiong Wang, Yaying Hao, Lüye Liu, Xue Yao, Xiuju Yao, Yi Wei, Xiaobin Sun, Yuanbiao Guo

      • Resumen

      págs. 1964-1974

      

    • Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors

      Chang Liu, Zhenxing Wang, Qian Liu, Guangyao Wu, Chunhong Chu, Lanxin Li, Lei An, Shaofeng Duan

      • Resumen

      págs. 1975-1985

      

    • Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer

      Junqun Liao, Yuan Ye, Xuren Xu

      • Resumen

      págs. 1986-1997

      

    • HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC

      Xiaoyan Wang, Yun Zhou, Chunfu Wang, Yanyan Zhao, Yan Cheng, Suhuai Yu, Xiaofeng Li, Wenjing Zhang, Ying Zhang, Huiqin Quan

      • Resumen

      págs. 1998-2009

      

    • Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group

      M. Sánchez Cánovas, David Fernández Garay, L. Ortega Morán, J. Rubio Pérez, Carlos Miguel Guirao Rubio, Miriam Lobo de Mena, B. Obispo Portero, Jesús Brenes Castro, Yolanda Lage Alfranca, Diego Cacho Lavín, Ana Belen Rupérez Blanco, Ana Manuela Martín Fernández de Soignie, Jonatan Zacarías Benoit Perejón, L. Jiménez Colomo, Noel Blaya Boluda, Javier Bosque Moreno, M.T. Quintanar Verdúguez, M. Carmen Rosa Garrido, Roberto Martín, Carme Font Puig, Andrés Jesús Muñoz Martín

      • Resumen

      págs. 2010-2020

      

    • MiR-507 inhibits the progression of gastric carcinoma via targeting CBX4-mediated activation of Wnt/β-catenin and HIF-1α pathways

      Xin Fang, Anping Pan

      • Resumen

      págs. 2021-2028

      

    • Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma

      Qiwei Zhang, Weiwei Rui, Yongsheng Jiang, Fei Yuan, Yong Chen, Xiaoxia Guo, Yu Zhou, Zhiyuan Wu, Chaofu Wang, Xiaoyi Ding

      • Resumen

      págs. 2029-2038

      

  • Brief Research Article

    • Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience

      G. Francolini, R. Campi, V. Di Cataldo, Beatrice Detti, M. Loi, Luca Triggiani, Salvatore La Mattina, P. Borghetti, S. M. Magrini, Luca Nicosia, Filippo Alongi, Paolo Ghirardelli, Vittorio Vavassori, Andrea Gaetano Allegra, Michele Aquilano, Erika Scoccimarro, Anna Peruzzi, Pierpaolo Pastina, L. Visani, Isacco Desideri, S. Serni, Icro Meattini, L. Livi

      • Resumen

      págs. 2039-2043

      

  • Correction

    • Correction to. Emerging roles of JMJD3 in cancer

      Maryam Farzaneh, Zeinab Kuchaki, Fatima Rashid Sheykhahmad, Seyed Mohammadmahdi Meybodi, Yusef Abbasi, Effat Gholami, Farhoodeh Ghaedrahmati, Omid Anbiayee

      págs. 2044-2044